Cargando…
Anti-amyloid-beta to tau-based immunization: developments in immunotherapy for Alzheimer’s disease
Immunotherapy might provide an effective treatment for Alzheimer’s disease (AD). A unique feature of AD immunotherapies is that an immune response against a self-antigen needs to be elicited without causing adverse autoimmune reactions. Current research is focused on two possible targets in this reg...
Autores principales: | Lambracht-Washington, Doris, Rosenberg, Roger N |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4051350/ https://www.ncbi.nlm.nih.gov/pubmed/24926455 http://dx.doi.org/10.2147/ITT.S31428 |
Ejemplares similares
-
Active full-length DNA Aβ(42) immunization in 3xTg-AD mice reduces not only amyloid deposition but also tau pathology
por: Rosenberg, Roger N., et al.
Publicado: (2018) -
Glial cell transcriptome analyses in 3xTg-AD mice: Effects of aging, disease progression, and anti-Aβ immunotherapy
por: Lambracht-Washington, Doris, et al.
Publicado: (2023) -
Evaluation of a DNA Aβ42 vaccine in adult rhesus monkeys (Macaca mulatta): antibody kinetics and immune profile after intradermal immunization with full-length DNA Aβ42 trimer
por: Lambracht-Washington, Doris, et al.
Publicado: (2017) -
Changes in the brain transcriptome after DNA Aβ42 trimer immunization in a 3xTg-AD mouse model
por: Lambracht-Washington, Doris, et al.
Publicado: (2020) -
Amyloid-beta immunotherapy: the hope for Alzheimer disease?
por: Barrera-Ocampo, Alvaro, et al.
Publicado: (2016)